*ST双成：注射用紫杉醇（白蛋白结合型）ANDA已获得美国FDA上市许可批准并已在美国实现出口销售

Core Viewpoint - The company has received FDA approval for its injectable paclitaxel (albumin-bound) and has commenced export sales to the United States [2] Group 1 - The company’s injectable paclitaxel (albumin-bound) is available in a specification of 100 mg per bottle [2] - The company confirmed that the product information will be disclosed in accordance with legal regulations [2] - The company will provide updates through designated disclosure media and the Giant Tide Information Network [2]